hemagglutinin inhibitors (Roche)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namehemagglutinin inhibitors (Roche)
Drug Alias Nameinfluenza fusion inhibitors (Roche)HA inhibitors (Roche)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInfluenza virus hemagglutinin glycoproteins inhibitors
TargetsInfluenza virus hemagglutinin glycoproteins
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesRoche Holding Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding Ag
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A